(Q41591016)

4 October 2017

title

Testosterone therapy and risk of myocardial infarction: a pharmacoepidemiologic study (English)

1 reference

4 October 2017

1 reference

James M Brophy

5

0 references

Bruce C Carleton

object named as

Bruce Carleton

4

0 references

author name string

Mahyar Etminan

1

1 reference

4 October 2017

Sean C Skeldon

2

1 reference

4 October 2017

Sheldon Larry Goldenberg

3

1 reference

4 October 2017

language of work or name

English

0 references

publication date

13 January 2015

1 reference

4 October 2017

1 reference

4 October 2017

volume

35

1 reference

4 October 2017

issue

1

1 reference

4 October 2017

page(s)

72-78

1 reference

Trends in androgen prescribing in the United States, 2001 to 2011.

4 October 2017

cites work

1 reference

Risks and benefits of testosterone therapy in older men.

21 January 2018

1 reference

Monkey business: reflections on testosterone

21 January 2018

1 reference

Low "T" as in "template": how to sell disease

21 January 2018

1 reference

Testosterone lab testing and initiation in the United Kingdom and the United States, 2000 to 2011.

21 January 2018

1 reference

Endogenous sex hormones and cardiovascular disease in men. A prospective population-based study

21 January 2018

1 reference

Endogenous testosterone and mortality due to all causes, cardiovascular disease, and cancer in men: European prospective investigation into cancer in Norfolk (EPIC-Norfolk) Prospective Population Study

21 January 2018

1 reference

Low serum testosterone and mortality in male veterans

21 January 2018

1 reference

Low serum testosterone and mortality in older men.

21 January 2018

1 reference

Low serum testosterone levels are associated with increased risk of mortality in a population-based cohort of men aged 20-79.

21 January 2018

1 reference

Endogenous testosterone and cardiovascular disease in healthy men: a meta-analysis

21 January 2018

1 reference

Testosterone treatment and mortality in men with low testosterone levels.

21 January 2018

1 reference

Adverse events associated with testosterone administration

21 January 2018

1 reference

Testosterone therapy and cardiovascular events among men: a systematic review and meta-analysis of placebo-controlled randomized trials.

21 January 2018

1 reference

Association of testosterone therapy with mortality, myocardial infarction, and stroke in men with low testosterone levels

21 January 2018

1 reference

Increased risk of non-fatal myocardial infarction following testosterone therapy prescription in men

21 January 2018

1 reference

Oral contraceptives and the risk of gallbladder disease: a comparative safety study

21 January 2018

1 reference

The association between drospirenone and hyperkalemia: a comparative-safety study

21 January 2018

1 reference

The nested case-control study in cardiology

21 January 2018

1 reference

Risk of acute myocardial infarction, stroke, heart failure, and death in elderly Medicare patients treated with rosiglitazone or pioglitazone

21 January 2018

1 reference

Positive predictive value of the diagnosis of acute myocardial infarction in an administrative database

21 January 2018

1 reference

Evaluating Medication Effects Outside of Clinical Trials: New-User Designs

21 January 2018

1 reference

COX-2 selective non-steroidal anti-inflammatory drugs and risk of serious coronary heart disease

21 January 2018

1 reference

Time variations in the risk of myocardial infarction among elderly users of COX-2 inhibitors

21 January 2018

1 reference

Overadjustment bias and unnecessary adjustment in epidemiologic studies

21 January 2018

1 reference

Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline

21 January 2018

1 reference

The Testosterone Trials: Seven coordinated trials of testosterone treatment in elderly men.

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/PHAR.1534

1 reference

4 October 2017

1 reference